Blog
RSS FeedPosted by Michael Wonder on 07 Mar 2024
Pharmaceutical reform agreement review report
6 March 2024 - The Department of Health and Aged Care has conducted a review of Pharmaceutical Reform Agreements (PRAs), to ...
Posted by Michael Wonder on 01 Nov 2022
1 November 2022 updates as part of the digital transformation of Authority Required (Written) PBS listings
1 November 2022 - From 1 November 2022, the PBS listings for certain medicines will be updated as part of the ...
Posted by Michael Wonder on 27 Oct 2022
Cheaper medicines legislation passed
27 October 2022 - The Australian Government’s legislation, which will see millions of Australians pay 29% less for scripts with the ...
Posted by Michael Wonder on 21 Oct 2022
PBS minimum stockholding requirements
21 October 2022 - Amendments made by the National Health Amendment Act 2021 give effect to the commitments in the new ...
Posted by Michael Wonder on 04 Oct 2022
2022 October price disclosure cycle – confirmed prices and patient savings reports
1 October 2022 - Combination flow-on reduction outcomes reflect confirmed 1 October 2022 prices on the Current Price Disclosure cycle web ...
Posted by Michael Wonder on 31 Jul 2022
2022 October price disclosure cycle – patient savings
29 July 2022 - Indicative brand price reductions and patient savings resulting from the 2022 October Cycle of Price Disclosure have ...
Posted by Michael Wonder on 04 Jul 2022
2022 October price disclosure cycle – indicative prices
4 July 2022 - Indicative 1 October 2022 prices resulting from the 2022 October Cycle of Price Disclosure have now been ...
Posted by Michael Wonder on 26 Jun 2022
Price disclosure 2022 October cycle outcomes summary
24 June 2022 - The summary of price disclosure price reductions for the 2022 October Cycle has now been published on ...
Posted by Michael Wonder on 08 Jun 2022
Updated price disclosure guidelines, price disclosure webpages and price disclosure dispute resolution process
8 June 2022 - Amendments made to the National Health Act 1953 and National Health (Pharmaceutical Benefits) Regulations 2017 by the ...
Posted by Michael Wonder on 25 May 2022
Remake of National Health (Supply of Pharmaceutical Benefits – Under Co-payment Data and Claims for Payment) Rules 2022
25 May 2022 - The Department has recently remade the National Health (Claims and under co-payment data) Rules 2012, now ...
Posted by Michael Wonder on 11 May 2022
Remake of the National Health (Pharmaceuticals and Vaccines – Cost Recovery) Regulations 2009
11 May 2022 - The Department has recently remade the National Health (Pharmaceutical and Vaccines—Cost Recovery) Regulations 2009 (2009 Regulations), ...
Posted by Michael Wonder on 15 Mar 2022
1 April 2022 price disclosure confirmed prices
15 March 2022 - Confirmed 1 April 2022 prices resulting from the 2022 April cycle of price disclosure have now been ...
Posted by Michael Wonder on 27 Jan 2022
2022 April price disclosure cycle – indicative prices
27 January 2022 - Indicative 1 April 2022 prices resulting from the 2022 April Cycle of Price Disclosure have now been ...
Posted by Michael Wonder on 22 Dec 2021
Extension to image based prescription special arrangement
22 December 2021 - The Department of Health has extended the ‘image based prescription’ interim measure which allows the supply of ...
Posted by Michael Wonder on 10 Dec 2021
Price disclosure 2022 April cycle outcomes summary
10 December 2021 - The summary of price disclosure price reductions for the 2022 April Cycle has now been published ...